AMMF - THE CHOLANGIOCARCINOMA CHARITY — grant history
Latest income
£1.0m
Grants listed (FY2024)
5
Listed grants total
£242k
Accounts grants total
£234k
listed grants reconcile with the accounts totalextracted from its FY2024 accounts
Application guidance — from the funder’s own website
- Deadlines: The next funding round opens for applications on 01 September, 2026.
What changed: FY2023 → FY2024
| Change | Grantee | FY2023 | FY2024 |
|---|---|---|---|
| new | University of Glasgow (Professor Chiara Braconi & Dr Jen Morton) | — | £99k |
| new | University of Oxford (Dr Shijie Cai) | — | £56k |
| new | University of Edinburgh (Professor Ed Jarman & Paula Olaizola) | — | £50k |
| new | University of Nottingham | — | £22k |
| new | Sapienza University of Rome | — | £15k |
| not listed | University of Copenhagen | £45k | — |
| not listed | University of Copenhagen (Professor Jesper B Andersen) | £45k | — |
| not listed | Sapienza University of Rome (Professor Carmine Mancone) | £35k | — |
| not listed | University of Edinburgh | £33k | — |
| not listed | University of Manchester, CR UK (Alicia-Marie Conway, Natalie Cook, Juan Valle, Dominic Rothwell) | £31k | — |
| not listed | Imperial College London (Shahid A Khan, Joshua B Edel, Aleksandar Ivanov, Micol Damiani) | £28k | — |
| not listed | Imperial College London | £28k | — |
| not listed | University of Nottingham (Kevin Gaston, Sheela Jayaraman, Isioma Egbuniwe) | £24k | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University of Glasgow (Professor Chiara Braconi & Dr Jen Morton) | FY2024 | £99k | Identifying therapeutic opportunities for Biliary Cancers by investigating the role of Monocytes in drug response |
| University of Oxford (Dr Shijie Cai) | FY2024 | £56k | Normal cholangiocyte containment of cholangiocarcinoma through metabolic and transcriptomic regulation |
| University of Edinburgh (Professor Ed Jarman & Paula Olaizola) | FY2024 | £50k | Does retinol from hepatic stellate cells fuel tumour cells during cholangiocarcinoma initiation |
| University of Nottingham | FY2024 | £22k | Combination therapies for cholangiocarcinoma |
| Sapienza University of Rome | FY2024 | £15k | The role of THBS1, THBS2 and PEDF in the lymphatic dissemination of the intrahepatic cholangiocarcinoma: identification of downstream signalling |
| University of Copenhagen | FY2023 | £45k | Award agreed to fund the work of Professor Jesper Andersen on “Tumour phenotypes and sensitivities triggered by IL-6 activation in intrahepatic cholangiocarcinoma”. |
| University of Copenhagen (Professor Jesper B Andersen) | FY2023 | £45k | To fund work on, “Tumour phenotypes and sensitivities triggered by IL-6 activation in intrahepatic cholangiocarcinoma” |
| Sapienza University of Rome (Professor Carmine Mancone) | FY2023 | £35k | To fund research into, “The role of THBS1, THBS2 and PEDF in the lymphatic dissemination of the intrahepatic cholangiocarcinoma: identification of downstream signalling” |
| University of Edinburgh | FY2023 | £33k | Award of £102,595 agreed in September 2017 to fund a 3 year PhD scholarship in Dr Luke Boulter's lab, for the project, " Understanding the role of seed cells and epithelian co-option in cholangiocarcinoma." |
| University of Manchester, CR UK (Alicia-Marie Conway, Natalie Cook, Juan Valle, Dominic Rothwell) | FY2023 | £31k | To rund research into, “Intrahepatic cholangiocarcinoma hidden amongst the unknown: biomarker discovery and novel diagnostic approach from circulation: Free DNA (cfDNA) in cancers of unknown primary”. |
| Imperial College London (Shahid A Khan, Joshua B Edel, Aleksandar Ivanov, Micol Damiani) | FY2023 | £28k | To fund research into, “Single-molecule multiplexed detection of biomarkers for HCC and CCA using a novel nanopore-based sensing”. |
| Imperial College London | FY2023 | £28k | Award agreed to fund the work of Professor Shahid Khan’s team in the detection of single-molecule multiplexed detection of biomarkers for HCC and CCA using a novel nanopore-based sensing. |
| University of Nottingham (Kevin Gaston, Sheela Jayaraman, Isioma Egbuniwe) | FY2023 | £24k | To fund research into, “Ultra high-resolution mapping of spatial patterns of gene and protein expression in cholangiocarcinoma and the cholangiocarcinoma tumour microenvironment”. |
| University of Liverpool | FY2023 | £24k | Award (of £25,000) agreed to fund the work of Dr Marc Quinn in the identification of actionable drug targets in perihilar cholangiocarcinoma using a whole exome sequencing approach. |
| University of Nottingham (Sheela Jayaraman, Anna Grabowksa, Kevin Gaston) | FY2023 | £22k | To fund work on combination therapies for cholangiocarcinoma. |
| Donostia University Hospital, Spain | FY2023 | £10k | Award of £32,048.00 agreed in 2019 to be given in 3 instalments to fund Dr Jesus Bañales’s work on the role of the transcription factor KLF5 in the etiopathogenesis of cholangiocarcinoma, a new diagnostic, prognostic and therapeutic strategy. |
| University of Leeds | FY2023 | £3k | Award of £45,000 which was agreed in July 2018 to be given over three years, to fund consumables required in the work of Dr Stephen Griffin on virus-driven intrahepatic cholangiocarcinoma. |